{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:54:21Z","timestamp":1777449261384,"version":"3.51.4"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["19ck0106271h0003"],"award-info":[{"award-number":["19ck0106271h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,23]]},"abstract":"<jats:p>Aspirin has gained great attention as a cancer preventive agent. Our previous study revealed that the low-dose aspirin prevents colorectal tumor recurrence in Japanese patients with colorectal adenomas and\/or adenocarcinomas, whereas aspirin increases risks in smokers and has no effects on regular drinkers. Our recent study revealed that aspirin reduces polyp growth in Japanese patients with familial adenomatous polyposis (FAP). In this study, we have studied the association of genotypes of alcohol metabolizing enzymes (ADH1B and ALDH2) on aspirin's efficacy of suppressing polyp growth (\u22655 mm) in a total of 81 Japanese patients with FAP. Our study revealed that aspirin showed significant preventive effects for patients with ADH1B-AA and AA+GA types [OR = 0.21; 95% confidence interval (CI), 0.05\u20130.95, and OR = 0.31; 95% CI, 0.10\u20130.95, respectively], and for patients with ALDH2-GG and GG+GA types (OR = 0.10; 95% CI, 0.01\u20130.92, and OR = 0.29; 95% CI, 0.09\u20130.94, respectively), but not for patients with ADH1B-GG and GA+GG types, and ALDH2-AA and GA+AA types. In addition, substantial preventive effects of aspirin were seen for patients with ADH1B-AA type who do not drink regularly (&amp;lt;3 times\/week, OR = 0.11; 95% CI, 0.02\u20130.78), where a statistically significant interaction between aspirin and ADH1B was observed (Pinteraction = 0.036). Results from this exploratory study strongly indicate that aspirin is beneficial in prevention of polyp growth for patients with FAP with ADH1B-AA and AA+GA types, and ALDH2-GG and GG+GA types. Taken together, we propose ADH1B and ALDH2 as candidate markers for the personalized prevention by aspirin.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Aspirin is beneficial to patients with FAP with ADH1B-AA and AA+GA types or ALDH2-GG and GG+GA types. ADH1B and ALDH2 genotypes can be the markers for the personalized prevention of colorectal cancer by aspirin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0088","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:56:26Z","timestamp":1653652586000},"page":"483-488","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Low-Dose Aspirin in Colorectal Cancer Risk Prevention is Dependent on\n                    <i>ADH1B<\/i>\n                    and\n                    <i>ALDH2<\/i>\n                    Genotype in Japanese Familial Adenomatous Polyposis Patients"],"prefix":"10.1158","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1395-0983","authenticated-orcid":true,"given":"Kanae","family":"Mure","sequence":"first","affiliation":[{"name":"1Department of Public Health, Wakayama Medical University School of Medicine, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"2Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan."},{"name":"3Ishikawa Gastroenterology Clinic, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Mutoh","sequence":"additional","affiliation":[{"name":"2Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan."},{"name":"4Epidemiology and Prevention Group, Research Center for Cancer Prevention and Screening\/Center for Public Health Sciences, National Cancer Center, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mano","family":"Horinaka","sequence":"additional","affiliation":[{"name":"5Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Otani","sequence":"additional","affiliation":[{"name":"6Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5988-4849","authenticated-orcid":true,"given":"Sadao","family":"Suzuki","sequence":"additional","affiliation":[{"name":"6Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"7Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Sakai","sequence":"additional","affiliation":[{"name":"5Department of Drug Discovery Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"J-FAPP Study IV group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Doyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tajika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Horimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Ezoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ikematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2468-1253(21)00018-2","article-title":"Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial","volume":"6","author":"Ishikawa","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gutjnl-2019-319438","article-title":"Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis","volume":"69","author":"Li","year":"2020","journal-title":"Gut"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/gutjnl-2013-305827","article-title":"The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial","volume":"63","author":"Ishikawa","year":"2014","journal-title":"Gut"},{"key":"2023031315090408700_","first-page":"245","article-title":"Overview: how is alcohol metabolized by the body?","volume":"29","author":"Zakhari","year":"2006","journal-title":"Alcohol Res Health"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/hep.1840060330","article-title":"Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism","volume":"6","author":"Bosron","year":"1986","journal-title":"Hepatology"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1470-2045(09)70019-1","article-title":"Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer","volume":"10","author":"Druesne-Pecollo","year":"2009","journal-title":"Lancet Oncol"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-13-2563","article-title":"Aspirin and colorectal cancer: back to the future","volume":"20","author":"Tougeron","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: the promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2023031315090408700_","article-title":"R: A language and environment for statistical computing: R Foundation for Statistical Computing","author":"R Core Team.","year":"2020"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.1990.03450180070031","article-title":"Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol","volume":"264","author":"Roine","year":"1990","journal-title":"JAMA"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cbi.2016.08.014","article-title":"Ethanol oxidation and the inhibition by drugs in human liver, stomach and small intestine: quantitative assessment with numerical organ modeling of alcohol dehydrogenase isozymes","volume":"258","author":"Chi","year":"2016","journal-title":"Chem Biol Interact"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2015.03.003","article-title":"Inhibition of human alcohol and aldehyde dehydrogenases by aspirin and salicylate: assessment of the effects on first-pass metabolism of ethanol","volume":"95","author":"Lee","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12253-014-9751-4","article-title":"Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer","volume":"20","author":"Kropotova","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cbi.2014.12.028","article-title":"Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls","volume":"234","author":"Singh","year":"2015","journal-title":"Chem Biol Interact"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jprot.2016.05.002","article-title":"Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases","volume":"142","author":"Shen","year":"2016","journal-title":"J Proteomics"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12864-017-4139-y","article-title":"A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer","volume":"18","author":"Durand","year":"2017","journal-title":"BMC Genomics"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41598-020-80563-z","article-title":"Further evidence supporting a potential role for ADH1B in obesity","volume":"11","author":"Morales","year":"2021","journal-title":"Sci Rep"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5487\/TR.2011.27.1.001","article-title":"Lipid peroxidation and its toxicological implications","volume":"27","author":"Nam","year":"2011","journal-title":"Toxicol Res"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2013","article-title":"Targeting aldehyde dehydrogenase 2: new therapeutic opportunities","volume":"94","author":"Chen","year":"2014","journal-title":"Physiol Rev"},{"key":"2023031315090408700_","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/TCRM.S88297","article-title":"Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt\/\u03b2-catenin signaling pathway","volume":"11","author":"Zhao","year":"2015","journal-title":"Ther Clin Risk Manag"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0088\/3153553\/crc-22-0088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/6\/483\/3282177\/crc-22-0088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/6\/483\/3282177\/crc-22-0088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:57:47Z","timestamp":1700625467000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/2\/6\/483\/704951\/Efficacy-of-Low-Dose-Aspirin-in-Colorectal-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,23]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0088","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22544058.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6550518","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6550518.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22544058","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}